Julia E. Tubert

1.2k total citations · 1 hit paper
18 papers, 590 citations indexed

About

Julia E. Tubert is a scholar working on Infectious Diseases, Health and Epidemiology. According to data from OpenAlex, Julia E. Tubert has authored 18 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Health and 4 papers in Epidemiology. Recurrent topics in Julia E. Tubert's work include SARS-CoV-2 and COVID-19 Research (10 papers), Vaccine Coverage and Hesitancy (8 papers) and COVID-19 Clinical Research Studies (6 papers). Julia E. Tubert is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (10 papers), Vaccine Coverage and Hesitancy (8 papers) and COVID-19 Clinical Research Studies (6 papers). Julia E. Tubert collaborates with scholars based in United States, South Africa and United Kingdom. Julia E. Tubert's co-authors include Bradley K. Ackerson, Carla Talarico, Katia Bruxvoort, Ana Florea, Lei Qian, Hung Fu Tseng, Gina S. Lee, Yi Luo, Lina S. Sy and Harpreet S. Takhar and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Julia E. Tubert

17 papers receiving 583 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

2022 315 citations Hung Fu Tseng, Bradley K. Ackerson et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julia E. Tubert United States	10	517	199	87	79	64	18	590
Heriberto García-Escorza Chile	6	568 1.1×	296 1.5×	48 0.6×	141 1.8×	40 0.6×	8	635
Paulina Leighton Chile	5	557 1.1×	292 1.5×	48 0.6×	140 1.8×	39 0.6×	5	623
Pamela Suárez Chile	5	557 1.1×	292 1.5×	48 0.6×	140 1.8×	39 0.6×	5	623
Francisco Cázares de León Mexico	3	478 0.9×	245 1.2×	43 0.5×	132 1.7×	35 0.5×	15	554
Roberto Dias de Oliveira Brazil	10	396 0.8×	167 0.8×	37 0.4×	74 0.9×	20 0.3×	29	476
Asad Zaidi United Kingdom	6	478 0.9×	77 0.4×	46 0.5×	172 2.2×	32 0.5×	13	588
Meagan E. Deming United States	9	486 0.9×	74 0.4×	66 0.8×	31 0.4×	108 1.7×	16	595
Natthinee Sudhinaraset Thailand	12	312 0.6×	98 0.5×	31 0.4×	51 0.6×	56 0.9×	29	370
Mayce Mansour United States	5	741 1.4×	56 0.3×	53 0.6×	148 1.9×	44 0.7×	6	901
Sathyavani Subbarao United Kingdom	9	225 0.4×	116 0.6×	23 0.3×	69 0.9×	28 0.4×	16	364

Countries citing papers authored by Julia E. Tubert

Since Specialization

Citations

This map shows the geographic impact of Julia E. Tubert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia E. Tubert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia E. Tubert more than expected).

Fields of papers citing papers by Julia E. Tubert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia E. Tubert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia E. Tubert. The network helps show where Julia E. Tubert may publish in the future.

Co-authorship network of co-authors of Julia E. Tubert

This figure shows the co-authorship network connecting the top 25 collaborators of Julia E. Tubert. A scholar is included among the top collaborators of Julia E. Tubert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia E. Tubert. Julia E. Tubert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Ku, Jennifer H, Afshan Nanji, Julia E. Tubert, et al.. (2024). Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System. American Journal of Ophthalmology. 263. 133–140.

Rayens, Emily, Jennifer H Ku, Lina S. Sy, et al.. (2024). Comparative Effectiveness of Cell‐Based Versus Egg‐Based Influenza Vaccines in Prevention of Influenza Hospitalization During the 2022–2023 Season Among Adults 18–64 Years. Influenza and Other Respiratory Viruses. 18(12). e70025–e70025. 2 indexed citations

Ku, Jennifer H, Emily Rayens, Lina S. Sy, et al.. (2024). Comparative Effectiveness of Licensed Influenza Vaccines in Preventing Influenza-related Medical Encounters and Hospitalizations in the 2022–2023 Influenza Season Among Adults ≥65 Years of Age. Clinical Infectious Diseases. 79(5). 1283–1292. 2 indexed citations

Tseng, Hung Fu, Bradley K. Ackerson, Katia Bruxvoort, et al.. (2023). Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nature Communications. 14(1). 189–189. 47 indexed citations

Ku, Jennifer H, Lina S. Sy, Lei Qian, et al.. (2023). Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study. Vaccine. 41(29). 4212–4219. 4 indexed citations

Ku, Jennifer H, Lina S. Sy, Lei Qian, et al.. (2023). Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study. Vaccine. 41(24). 3636–3646. 9 indexed citations

Tseng, Hung Fu, Bradley K. Ackerson, Lina S. Sy, et al.. (2023). mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States. Nature Communications. 14(1). 5851–5851. 36 indexed citations

Tseng, Hung Fu, Bradley K. Ackerson, Yi Luo, et al.. (2022). Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nature Medicine. 28(5). 1063–1071. 315 indexed citations breakdown →

Florea, Ana, Lina S. Sy, Yi Luo, et al.. (2022). Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study. PLoS ONE. 17(4). e0267824–e0267824. 17 indexed citations

10.

Florea, Ana, Lina S. Sy, Lei Qian, et al.. (2022). Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults. Clinical Infectious Diseases. 76(2). 252–262. 12 indexed citations

11.

Subbaraman, Meenakshi S., Julia E. Tubert, Yu Ye, et al.. (2022). Consumer Knowledge of Insurance Coverage of Alcohol Treatment Services in the United States: Changes Since 2015. Journal of Studies on Alcohol and Drugs. 83(6). 949–958. 1 indexed citations

12.

Tubert, Julia E., Laura Packel, Prosper Njau, et al.. (2021). HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania. AIDS Research and Therapy. 18(1). 21–21. 8 indexed citations

13.

Bruxvoort, Katia, Lina S. Sy, Lei Qian, et al.. (2021). Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study. The Lancet Regional Health - Americas. 6. 100134–100134. 64 indexed citations

14.

Bruxvoort, Katia, Lina S. Sy, Lei Qian, et al.. (2021). Real-World Effectiveness of the mRNA-1273 Vaccine Against COVID-19: Interim Results from a Prospective Observational Cohort Study. SSRN Electronic Journal. 29 indexed citations

15.

Malden, Deborah E., Katia Bruxvoort, Hung Fu Tseng, et al.. (2021). Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System — California, March–July 2021. MMWR Morbidity and Mortality Weekly Report. 70(40). 1415–1419. 10 indexed citations

16.

Rotheram‐Borus, Mary Jane, Adriane Wynn, Jackie Stewart, et al.. (2020). Outcomes of HIV-exposed but uninfected children in South Africa over 5 years. AIDS. 35(2). 347–349. 3 indexed citations

17.

Rotheram‐Borus, Mary Jane, Kodi B. Arfer, Joan Christodoulou, et al.. (2019). The association of maternal alcohol use and paraprofessional home visiting with children’s health: A randomized controlled trial.. Journal of Consulting and Clinical Psychology. 87(6). 551–562. 17 indexed citations

18.

Rotheram‐Borus, Mary Jane, Adriane Wynn, Ellen Almirol, et al.. (2019). Alcohol, But Not Depression or IPV, Reduces HIV Adherence Among South African Mothers Living with HIV Over 5 Years. AIDS and Behavior. 23(12). 3247–3256. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact